sr 95531 has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benway, TA; Brandner, S; Cummings, DM; Edwards, FA; Fernandes Freitas, MM; Ho, H; Lashley, T; Murray, CE; Richard-Loendt, A; Salih, DA; Shahab, L; Tedoldi, A | 1 |
| Debnath, ML; Klunk, WE; McClure, RJ; Pettegrew, JW | 1 |
2 other study(ies) available for sr 95531 and Alzheimer Disease
| Article | Year |
|---|---|
Neuronal and Peripheral Pentraxins Modify Glutamate Release and may Interact in Blood-Brain Barrier Failure.
Topics: Aged, 80 and over; Alzheimer Disease; Animals; Animals, Newborn; Blood-Brain Barrier; C-Reactive Protein; Evoked Potentials; Female; GABA Antagonists; Glutamic Acid; HEK293 Cells; Hippocampus; Humans; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Nerve Tissue Proteins; Neurons; Pyridazines; Serum Amyloid P-Component; Synapses | 2017 |
Inactivity of phosphoethanolamine, an endogenous GABA analog decreased in Alzheimer's disease, at GABA binding sites.
Topics: Alzheimer Disease; Animals; Ethanolamines; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Male; Muscimol; Pyridazines; Rats; Rats, Inbred F344; Receptors, GABA; Receptors, GABA-A; Receptors, GABA-B; Tritium | 1995 |